Outpatient Therapies for COVID-19

Hackensack Meridian Health is using Remdesivir at multiple sites across the health network for the treatment of mild to moderate COVID-19 under current scientific guidelines.

Remdesivir for the Treatment of COVID-19

Remdesivir is a three-day outpatient infusion treatment for the treatment of COVID-19 for patients who are not candidates for Paxlovid™. If you have COVID-19, your physician can refer you to an HMH hospital to determine whether you are eligible or would benefit from this treatment. This treatment is currently offered at:

• Hackensack University Medical Center
• JFK University Medical Center
• Jersey Shore University Medical Center
• Ocean University Medical Center